OpGen, Inc. (OPGN) financial statements (2022 and earlier)

Company profile

Business Address 9717 KEY WEST AVENUE
ROCKVILLE, MD 20850
State of Incorp. DE
Fiscal Year End December 31
SIC 8071 - Medical Laboratories (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments36,08013,3602,7084,5721,8474,1177,814
Cash and cash equivalents36,08013,3602,7084,5721,8474,1177,814
Receivables1,1726533,089374810542679
Inventory, net of allowances, customer advances and progress billings4,7121,486473544533692826
Inventory4,7121,486473544533692826
Other undisclosed current assets(2,222)1,388397293312330572
Total current assets:39,74316,8886,6675,7833,5025,6829,891
Noncurrent Assets
Inventory, Noncurrent3,4721,686     
Finance lease, right-of-use asset90450959
Operating lease, right-of-use asset1,8142,0821,044
Property, plant and equipment4,0123,2591311,2228368011,075
Intangible assets, net (including goodwill)21,98324,6061,4181,6861,9542,2222,526
Goodwill7,4538,025601601601601638
Intangible assets, net (excluding goodwill)14,53016,5818181,0851,3531,6211,889
Other noncurrent assets552780203259329280270
Total noncurrent assets:31,92432,8633,7553,1673,1183,3023,871
TOTAL ASSETS:71,66749,75110,4228,9506,6208,98413,763
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4,8955,4322,9593,5673,5994,0264,287
Accounts payable1,3071,8691,0561,6241,6922,2332,286
Accrued liabilities1,9661,4371,0479021,1611,215920
Employee-related liabilities1,6222,1278561,0427475781,081
Deferred revenue 1010
Debt14,5621,6641,9707981,1661,208252
Deferred revenue and credits2437355
Contract with customer, liability16
Other undisclosed current liabilities460265     
Total current liabilities:19,9177,3724,9394,3814,7905,2724,894
Noncurrent Liabilities
Long-term debt and lease obligation10,15720,9181,1901,0981301471,378
Long-term debt, excluding current maturities7,17619,379329660  1,000
Finance lease, liability447313
Capital lease obligations437130147378
Operating lease, liability2,9771,493547
Liabilities, other than long-term debt375269 163291398 
Deferred revenue and credits291398 
Deferred rent credit   163
Other liabilities147157     
Derivative instruments and hedges, liabilities229113     
Other undisclosed noncurrent liabilities   08  
Total noncurrent liabilities:10,53321,1881,1901,2614295451,378
Total liabilities:30,44928,5606,1285,6425,2195,8176,272
Stockholders' equity
Stockholders' equity attributable to parent41,21721,1914,2933,3091,4013,1677,491
Common stock465251568623253125
Additional paid in capital275,708219,129178,780165,314150,115136,199121,491
Accumulated other comprehensive income (loss)5862,547(17)(13)(26)6(1)
Accumulated deficit(235,542)(200,736)(174,525)(162,079)(148,710)(133,291)(114,124)
Total stockholders' equity:41,21721,1914,2933,3091,4013,1677,491
TOTAL LIABILITIES AND EQUITY:71,66749,75110,4228,9506,6208,98413,763

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues4,3064,2143,4992,9463,2114,0263,158
Revenue, net2,7723,5242,701
Cost of revenue(2,848)(1,015)(2,120)(1,452)(2,133)(2,290)(368)
Cost of goods and services sold    (2,133)(2,290)(368)
Gross profit:1,4583,1991,3791,4941,0781,7362,790
Operating expenses(24,731)(25,918)(13,650)(14,674)(16,344)(20,745)(18,217)
Other undisclosed operating income      368
Operating loss:(23,273)(22,718)(12,271)(13,180)(15,266)(19,009)(15,059)
Nonoperating expense(11,489)(3,360)(175)(188)(154)(157)(2,422)
Foreign currency transaction gain (loss), before tax891(1,469)2(10)23(8) 
Interest and debt expense259885(188)(191)(234)(143)(1,801)
Loss from continuing operations before equity method investments, income taxes:(34,503)(25,193)(12,634)(13,559)(15,653)(19,310)(19,282)
Other undisclosed income (loss) from continuing operations before income taxes(259)(885)1881912341431,801
Loss from continuing operations before income taxes:(34,762)(26,078)(12,446)(13,368)(15,419)(19,167)(17,481)
Income tax expense (benefit)(44)(132)    129
Net loss attributable to parent:(34,806)(26,211)(12,446)(13,368)(15,419)(19,167)(17,352)
Preferred stock dividends and other adjustments(7,167)    (333) 
Other undisclosed net loss available to common stockholders, basic      (244)
Net loss available to common stockholders, diluted:(41,972)(26,211)(12,446)(13,368)(15,419)(19,499)(17,596)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(34,806)(26,211)(12,446)(13,368)(15,419)(19,167)(17,352)
Comprehensive loss:(34,806)(26,211)(12,446)(13,368)(15,419)(19,167)(17,352)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(1,962)2,564(4)13(32)7(1)
Comprehensive loss, net of tax, attributable to parent:(36,767)(23,646)(12,451)(13,355)(15,451)(19,160)(17,353)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: